EUVIMEDEUVIMED entdecken
Crossref

Clioquinol improves Sepsis-induced immunosuppression and enhances host anti-infective defense by restoring macrophage phagocytic function

Biaoyu Guo, Chenyu Wang, Linlin Chen, Ting Chen, Xin Jiang, Zixin Li, Congna Zi, Yan Wang, Ye Tu, Zhibin Wang

International Immunopharmacology · 2026

DOI: 10.1016/j.intimp.2026.116893 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2026. Verfasst von Biaoyu Guo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, School of Anesthesiology, Naval Medical University, Shanghai, China; Department of Anesthesiology, The First Cl…. Hauptthemen laut MEDLINE: Sepsis, Clioquinol, Macrophages, Candidiasis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 97 Literaturangaben. Gefördert von: Hebei Provincial Natural Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Sepsis-induced immunosuppression is a core factor contributing to opportunistic infections and high mortality in patients, with macrophage phagocytic dysfunction being a critical component. Currently, effective therapeutic approaches to reverse macrophage phagocytic capacity remain limited. PATIENTS AND METHODS: The study employed an endotoxin-tolerant (ET) macrophage model and a mouse sepsis model induced by cecal ligation and perforation (CLP). The effects of clioquinol (ClioQ) on macrophage phagocytic function, inflammatory cytokine expression, and in vitro/in vivo clearance of fungi (Candida albicans, C. albicans) and bacteria (Escherichia coli, E. coli) were evaluated via flow cytometry-assessed phagocytosis, organ pathogen burden detection, and histopathological analysis. RESULTS: In the ET model, ClioQ treatment not only restored TNF-α secretion in response to lipopolysaccharide stimulation but also significantly rescued impaired phagocytosis and intracellular bactericidal functions. In the CLP-induced macrophage phagocytosis impairment model, ClioQ effectively improved macrophage phagocytosis of C. albicans and E. coli at non-antifungal pharmacological doses. In a secondary fungal infection model following CLP-induced sepsis, ClioQ (6 mg/kg) treatment significantly enhanced macrophage clearance efficiency against pathogens and markedly improved host survival. CONCLUSION: ClioQ was identified as a potential immunomodulator that enhances host defense capabilities by directly repairing phagocytic dysfunction in macrophages during the immunosuppressive phase of sepsis. This approach significantly improves organ injury and increases survival rates, offering a novel candidate strategy for immune-adjuvant therapy in sepsis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SepsisClioquinolMacrophagesCandidiasisAnimalsPhagocytosisMiceCandida albicansMaleEscherichia coliMice, Inbred C57BLDisease Models, AnimalImmune ToleranceHumansCytokinesTumor Necrosis Factor-alphaImmunosuppression Therapy

Stichwörter der Autor:innen

ClioquinolImmunosuppressionMacrophagePhagocytosisSepsis

Substanzen

ClioquinolCytokinesTumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Department of Critical Care Medicine, School of Anesthesiology, Naval Medical University, Shanghai, China; Department of Anesthesiology, The First Clinical Medical College, Hebei North University, Zhangjiakou, Hebei, Ch…
  • Department of Critical Care Medicine, School of Anesthesiology, Naval Medical University, Shanghai, China; School of Pharmacy, Naval Medical University, Shanghai, China.
  • Department of Critical Care Medicine, School of Anesthesiology, Naval Medical University, Shanghai, China.
  • School of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China.
  • Department of Anesthesiology, The First Clinical Medical College, Hebei North University, Zhangjiakou, Hebei, China. Electronic address: zicongna868@163.com.
  • School of Pharmacy, Naval Medical University, Shanghai, China. Electronic address: wangyancn@smmu.edu.cn.

Förderung

  • Hebei Provincial Natural Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Guo, B., Wang, C., Chen, L., Chen, T., Jiang, X., Li, Z., Zi, C., Wang, Y., Tu, Y., & Wang, Z. (2026). Clioquinol improves Sepsis-induced immunosuppression and enhances host anti-infective defense by restoring macrophage phagocytic function. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.116893

Vancouver

Guo B, Wang C, Chen L, Chen T, Jiang X, Li Z, et al. Clioquinol improves Sepsis-induced immunosuppression and enhances host anti-infective defense by restoring macrophage phagocytic function. International Immunopharmacology. 2026. doi:10.1016/j.intimp.2026.116893

BibTeX
@article{Guo2026,
  author = {Guo, Biaoyu and Wang, Chenyu and Chen, Linlin and Chen, Ting and Jiang, Xin and Li, Zixin and Zi, Congna and Wang, Yan and Tu, Ye and Wang, Zhibin},
  title = {Clioquinol improves Sepsis-induced immunosuppression and enhances host anti-infective defense by restoring macrophage phagocytic function},
  journal = {International Immunopharmacology},
  year = {2026},
  doi = {10.1016/j.intimp.2026.116893}
}
Kostenlos starten →